Physician profile
Akash Patel
NPI 1235557927
$10,052.36
in general payments reported to CMS, 2019-2025
38 companies · $3,378 in 2025
The $3,378 reported for 2025 was more than what 81% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.07 · 2020: $77.56 · 2021: $330 · 2022: $938 · 2023: $1,289 · 2024: $4,010 · 2025: $3,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,424 · Travel and Lodging: $1,236 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,424.19 |
| Travel and Lodging | $1,236.19 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,147.82 | 2021-2025 | |
| Medtronic, INC. | $1,515.88 | 2024 | Illumisite |
| Pfizer INC. | $1,232.93 | 2023-2025 | |
| Amgen INC. | $475.70 | 2020-2025 | Uplizna |
| Tg Therapeutics, INC. | $426.20 | 2023-2025 | |
| Biogen, INC. | $425.03 | 2022-2025 | Vumerity, Tysabri, Avonex |
| Argenx US, INC. | $405.60 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $394.82 | 2023-2025 | Rystiggo, Zilbrysq, Briviact |
| Lilly USA, LLC | $371.04 | 2024-2025 | Kisunla, Emgality, Amyvid |
| Novartis Pharmaceuticals Corporation | $279.25 | 2020-2025 | |
| Eisai INC. | $236.87 | 2024-2025 | |
| Emd Serono, INC. | $204.40 | 2022-2024 | Mavenclad |
| Genentech USA, INC. | $197.78 | 2020-2025 | Ocrevus Zunovo, Ocrevus |
| Biohaven Pharmaceutical Holding Company LTD. | $177.77 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $164.71 | 2023-2025 | Hyqvia |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.